Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
879 | 2991 | 40.9 | 66% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1745167 |
489 | 3 | CISPLATIN//STABILITY CONSTANTS//JOURNAL OF INORGANIC BIOCHEMISTRY | 23107 |
1065 | 2 | CISPLATIN//NEPHROTOXICITY//PLATINUMII COMPLEXES | 9996 |
879 | 1 | TRANSPLATIN//TRANSPLATINUM//BBR3464 | 2991 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TRANSPLATIN | authKW | 170094 | 1% | 56% | 30 |
2 | TRANSPLATINUM | authKW | 145166 | 1% | 89% | 16 |
3 | BBR3464 | authKW | 132276 | 1% | 72% | 18 |
4 | PLATINUM COMPLEXES | authKW | 93844 | 3% | 9% | 99 |
5 | DINUCLEAR PLATINUM | authKW | 72583 | 0% | 89% | 8 |
6 | CISPLATIN | authKW | 68767 | 9% | 3% | 262 |
7 | JOURNAL OF INORGANIC BIOCHEMISTRY | journal | 67510 | 6% | 3% | 193 |
8 | PLATINUM DRUGS | authKW | 55429 | 1% | 23% | 24 |
9 | CISPLATIN ANALOGUES | authKW | 48626 | 0% | 53% | 9 |
10 | POLYMERASE STOP ASSAY | authKW | 42528 | 0% | 83% | 5 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Inorganic & Nuclear | 30738 | 36% | 0% | 1079 |
2 | Biochemistry & Molecular Biology | 2930 | 29% | 0% | 860 |
3 | Chemistry, Multidisciplinary | 2136 | 20% | 0% | 584 |
4 | Chemistry, Medicinal | 1469 | 7% | 0% | 217 |
5 | Biophysics | 427 | 5% | 0% | 162 |
6 | Oncology | 417 | 8% | 0% | 246 |
7 | Toxicology | 286 | 4% | 0% | 111 |
8 | Pharmacology & Pharmacy | 278 | 8% | 0% | 248 |
9 | Crystallography | 134 | 2% | 0% | 74 |
10 | Chemistry, Physical | 18 | 5% | 0% | 157 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | COMANDO AERONAUT | 30622 | 0% | 100% | 3 |
2 | DEPENS | 30622 | 0% | 100% | 3 |
3 | ENSINO AERONAUT | 27217 | 0% | 67% | 4 |
4 | KILU | 23327 | 0% | 57% | 4 |
5 | CHEM PHYS OPT | 20658 | 1% | 8% | 24 |
6 | DIPARTIMENTO FARMACOCHIM | 20604 | 2% | 5% | 45 |
7 | KLIN DIEREXPT | 20414 | 0% | 100% | 2 |
8 | FAK CHEM CHEM BIOL CCB | 20410 | 0% | 50% | 4 |
9 | CHIM BIOCHIM PHARMACOL TOXICOL | 18311 | 1% | 5% | 33 |
10 | DISCIPLINE BIOMED SCI | 14417 | 1% | 9% | 15 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF INORGANIC BIOCHEMISTRY | 67510 | 6% | 3% | 193 |
2 | INORGANICA CHIMICA ACTA-BIOINORGANIC CHEMISTRY | 38647 | 2% | 7% | 58 |
3 | JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY | 25475 | 2% | 4% | 71 |
4 | INORGANIC CHEMISTRY | 16429 | 9% | 1% | 267 |
5 | INORGANICA CHIMICA ACTA | 13964 | 5% | 1% | 153 |
6 | METAL IONS IN BIOLOGICAL SYSTEMS | 4122 | 0% | 3% | 13 |
7 | ANTI-CANCER DRUG DESIGN | 3163 | 0% | 2% | 14 |
8 | JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS | 2282 | 2% | 0% | 54 |
9 | CHEMICO-BIOLOGICAL INTERACTIONS | 2152 | 1% | 1% | 35 |
10 | BIOCHEMISTRY | 1649 | 3% | 0% | 97 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TRANSPLATIN | 170094 | 1% | 56% | 30 | Search TRANSPLATIN | Search TRANSPLATIN |
2 | TRANSPLATINUM | 145166 | 1% | 89% | 16 | Search TRANSPLATINUM | Search TRANSPLATINUM |
3 | BBR3464 | 132276 | 1% | 72% | 18 | Search BBR3464 | Search BBR3464 |
4 | PLATINUM COMPLEXES | 93844 | 3% | 9% | 99 | Search PLATINUM+COMPLEXES | Search PLATINUM+COMPLEXES |
5 | DINUCLEAR PLATINUM | 72583 | 0% | 89% | 8 | Search DINUCLEAR+PLATINUM | Search DINUCLEAR+PLATINUM |
6 | CISPLATIN | 68767 | 9% | 3% | 262 | Search CISPLATIN | Search CISPLATIN |
7 | PLATINUM DRUGS | 55429 | 1% | 23% | 24 | Search PLATINUM+DRUGS | Search PLATINUM+DRUGS |
8 | CISPLATIN ANALOGUES | 48626 | 0% | 53% | 9 | Search CISPLATIN+ANALOGUES | Search CISPLATIN+ANALOGUES |
9 | POLYMERASE STOP ASSAY | 42528 | 0% | 83% | 5 | Search POLYMERASE+STOP+ASSAY | Search POLYMERASE+STOP+ASSAY |
10 | PLATINUM | 40138 | 7% | 2% | 204 | Search PLATINUM | Search PLATINUM |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | STARHA, P , VANCO, J , TRAVNICEK, Z , (2017) PLATINUM COMPLEXES CONTAINING ADENINE-BASED LIGANDS: AN OVERVIEW OF SELECTED STRUCTURAL FEATURES.COORDINATION CHEMISTRY REVIEWS. VOL. 332. ISSUE . P. 1 -29 | 121 | 68% | 0 |
2 | BERNERS-PRICE, SJ , RONCONI, L , SADLER, PJ , (2006) INSIGHTS INTO THE MECHANISM OF ACTION OF PLATINUM ANTICANCER DRUGS FROM MULTINUCLEAR NMR SPECTROSCOPY.PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY. VOL. 49. ISSUE 1. P. 65-98 | 116 | 78% | 89 |
3 | SHERMAN, SE , LIPPARD, SJ , (1987) STRUCTURAL ASPECTS OF PLATINUM ANTICANCER DRUG-INTERACTIONS WITH DNA.CHEMICAL REVIEWS. VOL. 87. ISSUE 5. P. 1153-1181 | 110 | 91% | 888 |
4 | BRABEC, V , (2002) DNA MODIFICATIONS BY ANTITUMOR PLATINUM AND RUTHENIUM COMPOUNDS: THEIR RECOGNITION AND REPAIR.PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 71. VOL. 71. ISSUE . P. 1 -68 | 138 | 65% | 169 |
5 | JAMIESON, ER , LIPPARD, SJ , (1999) STRUCTURE, RECOGNITION, AND PROCESSING OF CISPLATIN-DNA ADDUCTS.CHEMICAL REVIEWS. VOL. 99. ISSUE 9. P. 2467-2498 | 113 | 38% | 1671 |
6 | KOZELKA, J , (2009) MOLECULAR ORIGIN OF THE SEQUENCE-DEPENDENT KINETICS OF REACTIONS BETWEEN CISPLATIN DERIVATIVES AND DNA.INORGANICA CHIMICA ACTA. VOL. 362. ISSUE 3. P. 651 -668 | 99 | 77% | 25 |
7 | NATILE, G , MARZILLI, LG , (2006) NON-COVALENT INTERACTIONS IN ADDUCTS OF PLATINUM DRUGS WITH NUCLEOBASES IN NUCLEOTIDES AND DNA AS REVEALED BY USING CHIRAL SUBSTRATES.COORDINATION CHEMISTRY REVIEWS. VOL. 250. ISSUE 11-12. P. 1315-1331 | 91 | 91% | 32 |
8 | AHMAD, S , ISAB, AA , ALI, S , (2006) STRUCTURAL AND MECHANISTIC ASPECTS OF PLATINUM ANTICANCER AGENTS.TRANSITION METAL CHEMISTRY. VOL. 31. ISSUE 8. P. 1003-1016 | 111 | 76% | 16 |
9 | VINJE, J , SLETTEN, E , (2007) NMR SPECTROSCOPY OF ANTICANCER PLATINUM DRUGS.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. VOL. 7. ISSUE 1. P. 35 -54 | 101 | 72% | 17 |
10 | ARIS, SM , FARRELL, NP , (2009) TOWARDS ANTITUMOR ACTIVE TRANS-PLATINUM COMPOUNDS.EUROPEAN JOURNAL OF INORGANIC CHEMISTRY. VOL. . ISSUE 10. P. 1293-1302 | 71 | 83% | 80 |
Classes with closest relation at Level 1 |